These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33004251)

  • 21. Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study.
    Wan T; Köhn N; Kröll D; Berzigotti A
    Obes Surg; 2021 Feb; 31(2):702-711. PubMed ID: 32959331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bariatric surgery and non-alcoholic fatty liver disease.
    Julià H; Benaiges D; Pedro-Botet J
    Med Clin (Barc); 2022 Jun; 158(11):550-555. PubMed ID: 35120767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery.
    Cheng X; Fu Z; Xie W; Zhu L; Meng J
    Front Endocrinol (Lausanne); 2022; 13():1072513. PubMed ID: 36619535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
    de Brito E Silva MB; Tustumi F; de Miranda Neto AA; Dantas ACB; Santo MA; Cecconello I
    Obes Surg; 2021 Jun; 31(6):2762-2772. PubMed ID: 33846949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients.
    Petrick A; Benotti P; Wood GC; Still CD; Strodel WE; Gabrielsen J; Rolston D; Chu X; Argyropoulos G; Ibele A; Gerhard GS
    Obes Surg; 2015 Dec; 25(12):2368-75. PubMed ID: 26003548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial.
    Sherf-Dagan S; Zelber-Sagi S; Zilberman-Schapira G; Webb M; Buch A; Keidar A; Raziel A; Sakran N; Goitein D; Goldenberg N; Mahdi JA; Pevsner-Fischer M; Zmora N; Dori-Bachash M; Segal E; Elinav E; Shibolet O
    Int J Obes (Lond); 2018 Feb; 42(2):147-155. PubMed ID: 28852205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity.
    Hernández-Aguilera A; Casacuberta N; Castañé H; Fibla M; Fernández-Arroyo S; Fort-Gallifa I; París M; Sabench F; Del Castillo D; Baiges-Gaya G; Rodríguez-Tomàs E; Sans T; Camps J; Joven J
    Biol Trace Elem Res; 2021 Dec; 199(12):4555-4563. PubMed ID: 33559024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
    Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
    Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Nonseverely Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sha Y; Huang X; Ke P; Wang B; Yuan H; Yuan W; Wang Y; Zhu X; Yan Y
    Obes Surg; 2020 May; 30(5):1660-1670. PubMed ID: 31912466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort.
    Koh ZJ; Salgaonkar HP; Lee WJJ; Kim GW; Tan CH; Cheng A; Lomanto D; So JBY; Dan YY; Shabbir A
    Obes Surg; 2019 Mar; 29(3):862-868. PubMed ID: 30515622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].
    Qian C; Zhu C; Gao J; Bu L; Zhou D; Li N; Qu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):61-67. PubMed ID: 29354901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients.
    Endo Y; Ohta M; Tada K; Nakanuma H; Saga K; Masuda T; Hirashita T; Iwashita Y; Ozeki Y; Masaki T; Inomata M
    Ann Gastroenterol Surg; 2019 May; 3(3):285-290. PubMed ID: 31131357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Laparoscopic Sleeve Gastrectomy on the Course of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients during One Year of Follow Up.
    Głuszyńska P; Łukaszewicz A; Diemieszczyk I; Chilmończyk J; Reszeć J; Citko A; Szczerbiński Ł; Krętowski A; Razak Hady H
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy.
    Ma B; Sun H; Zhu B; Wang S; Du L; Wang X; Qu S
    Obes Facts; 2021; 14(1):64-71. PubMed ID: 33352578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria.
    Baldwin D; Chennakesavalu M; Gangemi A
    Surg Obes Relat Dis; 2019 Dec; 15(12):2123-2130. PubMed ID: 31711944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy.
    Ruiz-Tovar J; Zubiaga L
    Surg Obes Relat Dis; 2019 Sep; 15(9):1447-1453. PubMed ID: 31204247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.